[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338500-105":59,"doc-detail-338500-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncology-research-2024-3212-1903-1919-a-comprehensive-and-systematic-analysis-of-dihydrolipoamide-s-acetyltransferase-dlat-as-a-novel-prognostic-biomarker-in-pan-cancer-and-glioma","ONCOLOGY RESEARCH 2024 32(12) - 1903-1919 - A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma","","Dihydrolipoamide S-acetyltransferase (DLAT), a subunit of the pyruvate dehydrogenase complex, is investigated for roles in tumor occurrence and progression, with focus on prognosis and immunotherapy response. Differential expression, diagnosis, prognosis, genetic/epigenetic alterations, tumor microenvironment features, stemness, immune infiltration, functional enrichment, single-cell signatures, and drug response are assessed using multiple computational tools. Glioma cell validation supports carcinogenic effects. Overall, DLAT is elevated across tumors, associates with immune infiltration and survival, links to RNA/DNA modification and cell-cycle pathways, and correlates with drug resistance and pro-tumor behaviors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncology-research-2024-3212-1903-1919-a-comprehensive-and-systematic-analysis-of-dihydrolipoamide-s-acetyltransferase-dlat-as-a-novel-prognostic-biomarker-in-pan-cancer-and-glioma/338500/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncology-research-2024-3212-1903-1919-a-comprehensive-and-systematic-analysis-of-dihydrolipoamide-s-acetyltransferase-dlat-as-a-novel-prognostic-biomarker-in-pan-cancer-and-glioma/338500.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is DLAT and why is it important in this study?","Question",{"text":112,"@type":113},"DLAT is a subunit of the pyruvate dehydrogenase complex involved in glycolysis/TCA-related metabolism. The study targets DLAT because its role in tumor progression, prognosis, and immunotherapy is not fully understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was DLAT systematically analyzed across cancers?",{"text":117,"@type":113},"The work used multiple computational tools to assess differential expression, diagnostic and prognostic signals, genetic and epigenetic alterations, tumor microenvironment, stemness, immune infiltration, functional enrichment, single-cell analysis, and drug response. Glioma-specific experiments were also used to validate effects in cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect DLAT to patient outcomes and tumor biology?",{"text":121,"@type":113},"DLAT expression increased in most tumors, especially glioma, and correlated with survival. It related to RNA modification genes, DNA methylation, immune infiltration (including CD4+ T cells, CD8+ T cells, Tregs, and cancer-associated fibroblasts), and pathways linked to cell cycle. Higher DLAT expression also associated with resistance to multiple compound classes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338500,1790193196,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","ONCOLOGY RESEARCH 2024 32(12): 1903-1919 ARTICLE  \nA comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma  \nHUI ZHOU\\#; ZHENGYU YU\\#; JING XU; ZHONGWANG WANG; YALI TAO; JINJIN WANG; PEIPEI YANG; JINRONG YANG*; TING NIU* Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China  \nKey words: Dihydrolipoamide S-acetyltransferase (DLAT), Glioma, Prognostic, Immunological  \nAbstract: Background: Dihydrolipoamide S-acetyltransferase (DLAT) is a subunit of the pyruvate dehydrogenase complex (PDC), a rate-limiting enzyme complex, that can participate in either glycolysis or the tricarboxylic acid cycle (TCA) . However, the pathogenesis is not fully understood. We aimed to perform a more systematic and comprehensive analysis of DLAT in the occurrence and progression of tumors, and to investigate its function inpatients’ prognosis and immunotherapy. Methods: The differential expression, diagnosis, prognosis, genetic and epigenetic alterations, tumor microenvironment, stemness, immune inﬁltration cells, function enrichment, single-cell analysis, and drug response across cancers were conducted based on multiple computational tools. Additionally, we validated its carcinogenic effect and possible mechanism in glioma cells. Results: We exhibited that DLAT expression was increased in most tumors, especially in glioma, and affected the survival of tumor patients. DLAT was related to RNA modiﬁcation genes, DNA methylation, immune inﬁltration, and immune inﬁltration cells, including CD4+ T cells, CD8+ T cells, Tregs, and cancer-associated ﬁbroblasts. Single-cell analysis displayed that DLAT might regulate cancer by mediating angiogenesis, inﬂammation, and stemness. Enrichment analysis revealed that DLAT might take part in the cell cycle pathway. Increased expression of DLAT leads tumor cells to be more resistant to many kinds of compounds, including PI3Kβ inhibitors, PKC inhibitors, HSP90 inhibitors, and MEK inhibitors. In addition, glioma cells with DLAT silence inhibited proliferation, migration, and invasion ability, and promoted cell apoptosis.  \nConclusion: We conducted a comprehensive analysis of DLAT in the occurrence and progression of tumors, and its possible functions and mechanisms. DLAT is a potential diagnostic, prognostic, and immunotherapeutic biomarker  \nfor cancer patients.  \nIntroduction  \nNowadays, the malignant tumor has become the primary cause of human death, and seriously affect the quality of life of patients. In addition to surgery, chemotherapy, radiotherapy, and targeted therapy, immunotherapy is also one of the crucial treatments for cancer patients [1] . However, the objective response rates are unsatisfactory in many cancer patients, and some patients often resist or  \n*Address correspondence to: Jinrong Yang, [yangjinrong@wchscu.cn](yangjinrong@wchscu.cn); Ting Niu, [niuting@wchscu.cn](niuting@wchscu.cn)  \n\\#These authors have contributed equally to this work and share the ﬁrst authorship  \nReceived: 28 November 2023; Accepted: 21 February 2024;  \nPublished: 13 November 2024  \nDoi: 10.32604/or.2024.048138  \nrelapse [2,3] . Therefore, it is necessary to explore novel targets and investigate their correlations with patients’prognosis and tumor immunity.  \nDihydrolipoamide S-acetyltransferase (DLAT) is subunit E2 of the pyruvate dehydrogenase complex (PDC) [4], which is a mitochondrial multienzyme complex that can participate in either glycolysis or the tricarboxylic acid cycle (TCA) cycle [5,6] . The reprogramming of cell metabolism is usually observed in cancer cells [7,8] . Cancer cells absorb and utilize much more glucose than normal cells, and take advantage of glycolysis metabolism than oxidative phosphorylation regardless of oxygen availability, this phenomenon was known as the Warburg effect or aerobic glycolysis [9] . A previous study reported that DLAT expression was increased in gastric c","cbCaiho4aW93rZPW","https://ap.wps.com/l/cbCaiho4aW93rZPW","pdf",27934483,17,"English","# Abstract\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background on immunotherapy and prognosis\n## Role of DLAT in metabolism and cancer\n# Materials and Methods\n## Data acquisition","[{\"question\":\"What is DLAT and why is it important in this study?\",\"answer\":\"DLAT is a subunit of the pyruvate dehydrogenase complex involved in glycolysis/TCA-related metabolism. The study targets DLAT because its role in tumor progression, prognosis, and immunotherapy is not fully understood.\"},{\"question\":\"How was DLAT systematically analyzed across cancers?\",\"answer\":\"The work used multiple computational tools to assess differential expression, diagnostic and prognostic signals, genetic and epigenetic alterations, tumor microenvironment, stemness, immune infiltration, functional enrichment, single-cell analysis, and drug response. Glioma-specific experiments were also used to validate effects in cells.\"},{\"question\":\"What key findings connect DLAT to patient outcomes and tumor biology?\",\"answer\":\"DLAT expression increased in most tumors, especially glioma, and correlated with survival. It related to RNA modification genes, DNA methylation, immune infiltration (including CD4+ T cells, CD8+ T cells, Tregs, and cancer-associated fibroblasts), and pathways linked to cell cycle. Higher DLAT expression also associated with resistance to multiple compound classes.\"}]","ONCOLOGY RESEARCH 2024 32(12) - 1903-1919 - A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma | PDF",1790023887,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7bcfb51cdb3caf8184daf181aefa9e7.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b664ec8964b51cef785950f589f73a56.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bd99c744238dda4cb5a8c1865645615.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/315493ff6f7eadb47d30270898da74de.webp",980,1385]